Physical Activity and Fatigue in Early Multiple Sclerosis (MS)

Betaferon Treatment and Exercise Data Gathering IN Early MS

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00882453

Acronym

BEGIN

Enrollment

1739

Registered

2009-04-16

Start date

2006-08-31

Completion date

2011-03-31

Last updated

2012-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

Physical Activity, Fatigue, RRMS, CIS

Brief summary

The purpose of this observational study is to obtain a survey on physical activity in patients who for the first time have experienced symptoms which indicate a high risk for developing multiple sclerosis (MS) and in patients with recently diagnosed MS, and to obtain information on factors potentially influencing the patients' level of activity.

Interventions

DRUGInterferon beta-1b (Betaseron, BAY86-5046)

Intravenous therapy according to product information

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Multiple sclerosis diagnosed within the last 12 months * Clinically isolated Syndrome (CIS), under Interferon-beta-1b treatment

Design outcomes

Primary

Measure	Time frame
Physical Activity and Fatigue	At baseline and at Month 24

Secondary

Measure	Time frame
Health-related Quality of Life	At baseline and at Month 24
Depression	At baseline and at Month 24

Countries

Australia, Austria, Bahrain, Belgium, Canada, Colombia, Czechia, Denmark, Egypt, France, Germany, Greece, Indonesia, Israel, Italy, Jordan, Kazakhstan, Kuwait, Lebanon, Mexico, Netherlands, Norway, Oman, Portugal, Slovenia, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, United Arab Emirates, United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026